2:37 PM
 | 
Feb 13, 2018
 |  BC Extra  |  Politics & Policy

FDA to hold rare disease workshop

FDA said it will hold a one-day public workshop on March 19 to solicit feedback on issues facing rare disease therapeutics developers, including best practices for adaptive study designs and analytic tools for trials with novel endpoints.

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD